feed,title,long_url,short_url
Benzinga,"FDA Approves First Redosable Gene Therapy, Krystal Biotech's Treatment For Skin Blistering Disorder",https://benzinga.com/general/biotech/23/05/32504799/fda-approves-first-redosable-gene-therapy-krystal-biotechs-treatment-for-skin-blistering-disorder,https://da.gd/mppo6k
